Benitec Biopharma (BNTC) Metrics: History & Chart

Benitec Biopharma Inc.(BNTC)

Biotechnology · Hayward, CA

$8.90-0.33 (-3.61%)

Delayed quote: Oct 6, 2026, 11:34 AM EDT

About Benitec Biopharma Inc.

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Hayward, CA

24 employees

benitec.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jerel A. Banks

View full financials

Third-Party DCF Estimate (FMP)	$2.67
Price Gap vs Third-Party Estimate	-71.10%

7D Total Return	-7.88%
30D Total Return	-27.21%
YTD Total Return	-31.48%
1Y Total Return	-33.31%
3Y Total Return	+207.66%
5Y Total Return	-84.45%
10Y Total Return	-97.37%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-31.48%
2025	+6.65%
2024	+291.02%
2023	+11.76%
2022	-93.51%
2021	-12.67%
2020

CAGR TTM	-33.18%
CAGR 3Y	+45.43%
CAGR 5Y	-31.08%
CAGR 10Y	-30.49%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	10.86
PE Ratio Avg TTM	396.83
PE Ratio Avg 3Y	396.83
Current VS TTM Avg	-97.26%
Current VS 3Y Avg	-97.26%
Current VS 5Y Avg	-97.26%

All Metrics

BNTC Valuation Metrics

BNTC Stock Price Metrics

BNTC Dividend Metrics

BNTC Growth Rate Metrics

BNTC Discounted Cash Flow Metrics

BNTC Returns By Period

BNTC Yearly Returns

BNTC Average Annual Returns By Period (CAGR)

BNTC Revenue Metrics

BNTC PE Ratio Metrics

BNTC PS Ratio Metrics

BNTC PB Ratio Metrics

BNTC Price to Free Cash Flow Ratio Metrics

BNTC Debt to Equity Ratio Metrics

BNTC PEG Ratio Metrics

BNTC FCF Yield

BNTC Earnings Yield

BNTC EBITDA Yield

BNTC OCF Yield

BNTC EV/EBIT Ratio Metrics

BNTC EV/EBITDA Ratio Metrics

BNTC EV/Assets Ratio Metrics

BNTC EV/Sales Ratio Metrics

BNTC Current Ratio Metrics

BNTC Quick Ratio Metrics

BNTC ROIC Metrics

BNTC Return on Assets Metrics

BNTC Return on Equity Metrics

BNTC Net Profit Margin Metrics

BNTC Gross Profit Margin Metrics

BNTC Tax Rate Metrics

PS Ratio	1073.00
PS Ratio Avg TTM	995.02
PS Ratio Avg 3Y	927.22
Current VS TTM Avg	+7.84%
Current VS 3Y Avg	+15.72%
Current VS 5Y Avg	+43.92%

PB Ratio	2.43
PB Ratio Avg TTM	3.95
PB Ratio Avg 3Y	4.11
Current VS TTM Avg	-38.47%
Current VS 3Y Avg	-40.94%
Current VS 5Y Avg	-36.76%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-32.33%
Current VS 3Y Avg	-61.12%
Current VS 5Y Avg	-87.68%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	9.20%
Earnings Yield Avg TTM	4.04%
Earnings Yield Avg 3Y	4.04%
Current VS TTM Avg	+127.53%
Current VS 3Y Avg	+127.53%
Current VS 5Y Avg	+127.53%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	8.58
Ev/Ebit Ratio Avg TTM	23.87
Ev/Ebit Ratio Avg 3Y	23.87
Current VS TTM Avg	-64.05%
Current VS 3Y Avg	-64.05%
Current VS 5Y Avg	-64.05%

Ev/Ebitda Ratio	8.08
Ev/Ebitda Ratio Avg TTM	22.81
Ev/Ebitda Ratio Avg 3Y	22.81
Current VS TTM Avg	-64.57%
Current VS 3Y Avg	-64.57%
Current VS 5Y Avg	-64.57%

Ev/Assets Ratio	1.37
Ev/Assets Ratio Avg TTM	2.88
Ev/Assets Ratio Avg 3Y	2.83
Current VS TTM Avg	-52.46%
Current VS 3Y Avg	-51.63%
Current VS 5Y Avg	-49.65%

Ev/Sales Ratio	742.27
Ev/Sales Ratio Avg TTM	727.13
Ev/Sales Ratio Avg 3Y	656.88
Current VS TTM Avg	+2.08%
Current VS 3Y Avg	+13.00%
Current VS 5Y Avg	+17.79%

Current Ratio	34.00
Current Ratio Avg TTM	52.03
Current Ratio Avg 3Y	26.19
Current VS TTM Avg	-34.65%
Current VS 3Y Avg	+29.81%
Current VS 5Y Avg	+111.08%

Quick Ratio	34.00
Quick Ratio Avg TTM	52.03
Quick Ratio Avg 3Y	26.19
Current VS TTM Avg	-34.65%
Current VS 3Y Avg	+29.81%
Current VS 5Y Avg	+111.08%

ROIC	(28.88%)
ROIC Avg 3Y	(50.55%)
ROIC Avg 5Y	(103.01%)
Current VS 3Y Avg	+42.88%
Current VS 5Y Avg	+71.97%
Current VS 10Y Avg	+63.90%

ROA	(24.94%)
ROA Avg TTM	(9.03%)
ROA Avg 3Y	(14.15%)
Current VS TTM Avg	-176.17%
Current VS 3Y Avg	-76.27%
Current VS 5Y Avg	-15.35%

ROE	(25.73%)
ROE Avg TTM	(35.78%)
ROE Avg 3Y	(41.47%)
Current VS TTM Avg	+28.09%
Current VS 3Y Avg	+37.96%
Current VS 5Y Avg	+71.85%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	(580.83%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	+100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+100.00%

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	10.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A